To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
A study to assess the pharmacokinetics, safety and tolerability of Selumetinib (AZD6244,
ARRY-142886) in subjects with renal impairment and healthy subjects